With MDMA, patients can revisit and process memories of traumatic experiences
Canadian company NeuroPharm Inc. files application with the U.S. Patent and Trademark Office in connection with a psychedelic therapy.
Australian researchers review the state of the evidence for using these drugs in the treatment of post-traumatic stress disorder
Numinus Wellness chief medical officer Dr. Evan Wood cautions that it’s not a cure for everybody—but trials have shown statistically significant results
Clinical trials of MDMA psychotherapy are going on at 15 sites in the U.S., Canada, and Israel